FDA Inspection 1060961 — Catherine Petit, MD

Catherine Petit, MD — FEI 3005296372

The FDA completed an inspection of Catherine Petit, MD on Jul 27, 2018 in Corbeil Essonnes Cedex. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 27, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Corbeil Essonnes Cedex (France)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance